基于移动设备的认知行为疗法对动脉粥样硬化性心血管疾病患者血脂水平的影响:多中心、前瞻性、随机对照试验研究方案
该研究为多中心、前瞻性随机对照试验,随访6个月,比较接受移动设备认知行为疗法(CBT)联合标准药物治疗的ASCVD患者与仅接受标准药物治疗的对照组在低密度脂蛋白胆固醇(LDL-C)等指标上的差异。研究计划在基线、1、3、6个月测量平均LDL-C水平、不同LDL-C水平的百分比、LDL变异系数、一般自我效能感量表(GSEs)及生活质量指数(QL-index)等。作者认为基于移动设备的CBT干预可能有效降低ASCVD患者的LDL-C水平。
要点
- 研究比较移动设备CBT联合标准药物治疗与单纯标准药物治疗对ASCVD患者LDL-C的影响。
- 两组均在标准药物治疗基础上,随访6个月,评估LDL-C、LDL变异系数、GSEs及QL-index等。
- 作者认为移动设备CBT干预可能有效降低ASCVD患者的LDL-C水平。
核心结论
- 作者认为实施基于移动设备的CBT干预可能有效降低ASCVD患者的LDL-C水平。
研究设计与样本
- 多中心、前瞻性随机对照试验,随访6个月,比较移动设备CBT联合标准药物治疗组与仅标准药物治疗对照组。
主要发现
- 计划在基线、1、3、6个月测量两组平均LDL-C水平、不同LDL-C水平的百分比、LDL变异系数、GSEs及QL-index等指标。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Atherosclerotic cardiovascular disease (ASCVD) remains a major source of mortality in China. Convincing evidence has demonstrated that the reduction of low-density lipoprotein cholesterol (LDL-C) is correlated with lowering ASCVD risk. The efficacy of lifestyle management in lipid levels reduction has been confirmed in numerous studies. However, considering that low compliance to lifestyle management has limited the benefits of lowering lipid levels, cognitive behavior therapy (CBT) is proposed as a solution to improve clinical outcomes. The objective of this trial is to compare the LDL-C outcome in ASCVD patients receiving mobile device-based CBT to a control group, with both groups under standard pharmacological treatments. METHODS: This trial is designed as a multicenter, prospective randomized controlled trial with a 6-month follow-up. Mean LDL-C level and the percentage of different LDL-C levels, coefficient of variation of LDL, General Self-Efficacy Scale (GSEs), quality of life index (QL-index), etc., between the two groups at baseline, 1, 3, and 6 months will be measured. DISCUSSION: This trial should demonstrate that the implementation of mobile-based CBT intervention will be potentially effective in lowering LDL-C levels in ASCVD patients. TRIAL REGISTRATION: Chinese Clinical Trial Registry ( ChiCTR2100046775 ) [registered: 2021/5/28].
引用
- Hong XL, Luan Y, Liu HY, et al. Effect of mobile-based cognitive behavior therapy (CBT) on lowering of blood lipid levels in atherosclerotic cardiovascular disease (ASCVD) patients: study protocol for a multicenter, prospective, randomized controlled trial. Trials. 2022. PMID: 35773718. doi:10.1186/s13063-022-06459-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。